Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Innovotech Inc V.IOT

Innovotech Inc. is a Canada-based biotechnology company. The Company is engaged in owning intellectual property, conducting contract research, and owning and providing devices for testing in multiple applications in microbiology. Its contract research services include Antimicrobial Contract Research; Antimicrobial and Anti-Biofilm Agents, including Minimum Inhibitory Concentration (MIC) and Minimum Biofilm; Eradication Concentration (MBEC); Antimicrobial and Anti-Biofilm Materials, including TM100, ISO 22196 and USP 51; Customized Antimicrobial Testing, including BEST Assay Testing and Implanted Medical Device Testing; Bacteriophage Testing; and Analytical Capabilities. It also offers MBEC Assay Kits, Order Biofilm Assays and Coated MBEC Assay Lids. Its biofilm research includes The Science of Biofilms, Biofilm Publications and SEM Library. Its antimicrobial silver products include AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products.


TSXV:IOT - Post by User

Bullboard Posts
Post by DerekForealon Apr 16, 2015 9:29pm
62 Views
Post# 23638868

Teleflex

Teleflex

November 2014- "US Army grant for anti-biofilm orthopedic device/ $2.1 million grant will have Teleflex working to combine Semprus Sustain technology & antimicrobial release to reduce orthopedic infections"

2010"Our recent project with Teleflex is yet another demonstration of Innovotech's expertise in microbial biofilms and its distinguished track record in meeting client's needs," said Ken Boutilier, President and CEO of Innovotech Inc. 
 "Innovotech's sense of urgency, understanding of the requirements and their extensive commercial knowledge of biofilm microbiology were significant contributing factors in the development and execution of external efficacy testing for submission." Barry McBride, Teleflex Chief Technology Officer

Teleflex has been satisfied with Innovotech's work in the past and hopefully it will require its expertise once more with this biofilm related research project! 
Bullboard Posts